CASO, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 1.694
EU - Europa 843
AS - Asia 275
AF - Africa 28
SA - Sud America 7
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 2.854
Nazione #
US - Stati Uniti d'America 1.634
IT - Italia 352
CN - Cina 232
IE - Irlanda 132
NL - Olanda 106
FR - Francia 93
CA - Canada 57
FI - Finlandia 49
SE - Svezia 38
CI - Costa d'Avorio 23
DE - Germania 19
GB - Regno Unito 17
IN - India 12
VN - Vietnam 12
UA - Ucraina 11
SG - Singapore 7
ES - Italia 6
AU - Australia 5
BR - Brasile 5
CH - Svizzera 4
GR - Grecia 3
HR - Croazia 3
PL - Polonia 3
TN - Tunisia 3
EG - Egitto 2
EU - Europa 2
MX - Messico 2
PT - Portogallo 2
TR - Turchia 2
AR - Argentina 1
BE - Belgio 1
BG - Bulgaria 1
CO - Colombia 1
HK - Hong Kong 1
ID - Indonesia 1
IL - Israele 1
IQ - Iraq 1
JP - Giappone 1
LI - Liechtenstein 1
LU - Lussemburgo 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PK - Pakistan 1
RO - Romania 1
TH - Thailandia 1
TW - Taiwan 1
Totale 2.854
Città #
Chandler 269
Millbury 177
Ashburn 130
Des Moines 115
Amsterdam 102
Princeton 98
Naples 90
Nanjing 83
Boston 76
Napoli 69
Lawrence 63
Ottawa 48
Wilmington 41
Beijing 40
Nanchang 34
Washington 14
Woodbridge 13
Dong Ket 12
Hebei 12
Jacksonville 12
Shenyang 12
Fairfield 11
Jiaxing 10
Tianjin 10
Redwood City 9
Dublin 8
Rome 8
Toronto 8
Kunming 7
Seattle 6
Changsha 5
Norwalk 5
Singapore 5
Boardman 4
Campinas 4
Campoli del Monte Taburno 4
Fremont 4
Lanzhou 4
Pune 4
Battipaglia 3
Cantagallo 3
Caserta 3
Cassano d'Adda 3
Castel San Giorgio 3
Coimbatore 3
Hangzhou 3
Houston 3
Indiana 3
Marsala 3
Milan 3
Sydney 3
Torre Del Greco 3
Treviso 3
Udine 3
Aversa 2
Brisbane 2
Campoformido 2
Carlino 2
Casavatore 2
Casoria 2
Cuauhtémoc 2
Florence 2
Funchal 2
Gaiarine 2
Karditsa 2
Kerken 2
Kronberg 2
Lausanne 2
Nola 2
Orange 2
Phoenix 2
Porcia 2
Romainville 2
Salerno 2
San Francisco 2
San Genesio Ed Uniti 2
San Giorgio A Cremano 2
Solofra 2
Streatham 2
Wuhan 2
Zagreb 2
Zurich 2
Ankara 1
Bacoli 1
Baghdad 1
Bangalore 1
Bari 1
Binasco 1
Buenos Aires 1
Cairo 1
Casalnuovo di Napoli 1
Changchun 1
Civezzano 1
Cologne 1
Council Bluffs 1
Edmonton 1
Erba 1
Esslingen am Neckar 1
Falls Church 1
Foligno 1
Totale 1.745
Nome #
Mud-bath therapy and oral glucosamine sulfate in patients with knee osteoarthritis: A randomised, controlled, crossover study 67
Accelerated bone turnover identifies hemiplegic patients at higher risk of demineralization 48
Clinical effects of mud-bath therapy and oral glucosamine sulfate after 6 months of discontinuation in patients with knee osteoarthritis: results from a randomised, controlled, crossover study 47
The use of TNF-? blockers in psoriatic arthritis patients with latent tuberculosis infection. 45
Fragility Fractures in Patients with Psoriatic Arthritis 43
Comparison of effectiveness and safety ofinfliximab, etanercept, and adalimumab in psoriatic arthritis patients whoexperienced an inadequate response to previous disease-modifying antirheumaticdrugs. 42
Alopecia areata in a patient with psoriatic arthritis and Crohn's disease receiving etanercept 42
Small molecule therapy for managing moderate to severe psoriatic arthritis 41
Association between small dense LDL and sub-clinical atherosclerosis in patients with psoriatic arthritis 41
Dactylitis in enteropathic spondyloarthritis 40
Analysis of rheumatoid- vs psoriatic arthritis synovial fluid reveals differential macrophage (CCR2) and T helper subsets (STAT3/4 and FOXP3) activation 36
Interleukin-17A (IL-17A), a key molecule of innate and adaptive immunity, and its potential involvement in COVID-19-related thrombotic and vascular mechanisms 34
Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients 34
Rheumatic complaints in women taking aromatase inhibitors for treatment of hormone-dependent breast cancer. 33
Metabolic syndrome and its relationship with the achievement of minimal disease activity state in psoriatic arthritis patients: an observational study 33
Anakinra treatment in drug-resistant Behcet’s disease: a case series 33
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 32
Current evidence in the field of the management with TNF-α inhibitors in psoriatic arthritis and concomitant hepatitis C virus infection 31
Blau syndrome and latent tubercular infection: an unresolved partnership 30
Cardiovascular Risk Markers and Major Adverse Cardiovascular Events in Psoriatic Arthritis Patients 30
Symptomatic psoriatic dactylitis is associated with ultrasound determined extra-synovial inflammatory features and shorter disease duration 30
Amplifying the concept of psoriatic arthritis: The role of autoimmunity in systemic psoriatic disease 30
Biological treatments: new weapons in the management of monogenic autoinflammatory disorders 29
Paradoxical onset of psoriatic arthritis during treatment with biologic agents for plaque psoriasis: a combined dermatology and rheumatology clinical study. 28
Biomarkers of subclinical atherosclerosis in patients with psoriatic arthritis 28
Association between Leeds Dactylitis Index and ultrasonographic features: a multicentre study on psoriatic hand dactylitis 28
Mud-bath therapy and oral glucosamine sulfate in patients with knee osteoarthritis: a randomized, controlled, crossover study 28
Canakinumab efficacy in refractory adult-onset PFAPA syndrome 27
Minimal disease activity in patients with psoriatic arthritis treated with ustekinumab: results from a 24-week real-world study 27
Metabolic syndrome in psoriatic arthritis: the interplay with cutaneous involvement. Evidences from literature and a recent cross-sectional study 27
Coeliac disease is a risk factor for the development of seronegative arthritis in patients with autoimmune thyroid disease 27
IL-17-induced inflammation modulates the mPGES-1/PPAR-gamma pathway in monocytes/macrophages 27
Il methotrexate nella terapia dell'artrite periferica in corso di rettocolite ulcerosa 26
Vascular perfusion kinetics by contrast-enhanced ultrasound are related to synovial microvascularity in the joints of psoriatic arthritis 26
Psoriatic arthritis and psoriasis: differential diagnosis 25
Transcriptional network profile on synovial fluid T cells in psoriatic arthritis 25
Biological treatments in Behçet's disease: beyond anti-TNF therapy 25
Can hydroxychloroquine be useful in the prevention of COVID-19? An Italian survey in dermatologic and rheumatologic patients already under treatment 25
Effectiveness of steroid injection for hand psoriatic dactylitis: results from a multicentre prospective observational study 25
Pharmacological treatment of spondyloarthritis: exploring the effectiveness of nonsteroidal anti-inflammatory drugs, traditional disease-modifying antirheumatic drugs and biological therapies 24
The potential role of bone scintigraphy in the detection of deep muscular fascia involvement and calcinosis cutis in anti-synthetase syndrome 23
Serum amyloid-A in Beh?et's disease. 23
Simple clinical indicators for early psoriatic arthritis detection 23
Quantitative imaging by pixel-based contrast-enhanced ultrasound reveals a linear relationship between synovial vascular perfusion and the recruitment of pathogenic IL-17A-F(+)IL-23(+) CD161(+) CD4(+) T helper cells in psoriatic arthritis joints 23
Scores versus clinical profiles in therapeutic decisions: a positive example from the Italian Medicines Agency (AIFA) decisions in the field of osteoporosis 23
IL-17A neutralizing antibody regulates monosodium urate crystal-induced gouty inflammation 23
Emerging drugs for psoriatic arthritis 22
Progress in understanding and utilizing TNF-α inhibition for the treatment of psoriatic arthritis 22
Decrease of serum C-reactive protein levels in psoriatic arthritis patients treated with TNF alpha blockers 22
Diagnosis and classification of relapsing polychondritis 22
Magnetic resonance imaging of nail unit in psoriatic arthritis 22
From autoinflammation to autoimmunity: old and recent findings 21
Refractory pemphigus foliaceus and Beh?et?s disease successfully treated with tocilizumab 21
JAK/STAT/PKC? molecular pathways in synovial fluid T lymphocytes reflect the in vivo T helper-17 expansion in psoriatic arthritis 21
The definition and measurement of axial psoriatic arthritis 21
Treatment options: NSAIDs and DMARDs 21
Acute and chronic pain in orthopaedic and rheumatologic diseases: mechanisms and characteristics 21
Caveats and truths in genetic, clinical, autoimmune and autoinflammatory issues in Blau syndrome and early onset sarcoidosis 21
Long-term safety of anti-TNF-α in PsA patients with concomitant HCV infection: A retrospective observational multicenter study on 15 patients 21
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis 21
Pro-inflammatory adipokine profile in psoriatic arthritis: results from a cross-sectional study comparing PsA subset with evident cutaneous involvement and subset “sine psoriasis” 21
TNFα-inhibitors for ankylosing spondylitis and nonradiographic axial spondyloarthritis 21
The enthesopathy of celiac patients: Effects of gluten-free diet 21
Psoriatic disease: Clinical staging 20
Ex vivo signaling protein mapping in T lymphocytes in the psoriatic arthritis joints 20
Incidence of malignancies in a cohort of psoriatic arthritis patients taking traditional disease modifying antirheumatic drug and tumor necrosis factor inhibitor therapy: An observational study 20
Blau syndrome, clinical and genetic aspects 20
Autoinflammatory granulomatous diseases: from Blau syndrome and early-onset sarcoidosis to NOD2-mediated disease and Crohn's disease 20
Interaction between microbiome and host genetics in psoriatic arthritis 20
The anti-drug antibodies detection: a valuable tool for clinical response loss in psoriatic patients? 20
COVID-19 clinical spectrum in psoriatic arthritis patients on biologics and tsDMARDs: results from a cohort at an Italian epicentre of the pandemic's third wave 20
Bilateral dexamethasone intravitreal implant in a young patient with Vogt-Koyanagi-Harada disease and refractory uveitis 19
Psoriatic disease treatment nowadays: unmet needs among the "jungle of biologic drugs and small molecules". 19
Ultrasonographic Evidence of Predominance of Acute Extracapsular and Chronic Intrasynovial Patterns in 100 Cases of Psoriatic Hand Dactylitis 19
Early psoriatic arthritis 19
Ultrasound Effectiveness of Steroid Injection for hand Psoriatic Dactylitis: Results from a Longitudinal Observational Study 19
Psoriatic arthritis is associated with increased arterial stiffness in the absence of known cardiovascular risk factors: a case control study 18
Autoimmunity and autoinflammation as the yin and yang of idiopathic recurrent acute pericarditis 18
Role of Colchicine Treatment in Tumor Necrosis Factor Receptor Associated Periodic Syndrome (TRAPS): Real-Life Data from the AIDA Network 18
Efficacy of tocilizumab in a patient with refractory psoriatic arthritis 17
Monogenic autoinflammatory syndromes: state of the art on genetic, clinical, and therapeutic issues. 17
Impact of 24 months of anti-TNF therapy versus methotrexate on body weight in patients with rheumatoid arthritis: a prospective observational study 17
Role of agents other than tumor necrosis factor blockers in the treatment of psoriatic arthritis 17
Thalassemic Trait Prevalence in Patients Affected by Psoriatic Arthritis in Anti-TNF Treatment 17
Performances of five risk algorithms in predicting cardiovascular events in patients with Psoriatic Arthritis: An Italian bicentric study 17
Predominant ultrasonographic extracapsular changes in symptomatic psoriatic dactylitis: results from a multicenter cross-sectional study comparing symptomatic and asymptomatic hand dactylitis 17
Erratum: Management of adult-onset Still's disease with interleukin-1 inhibitors: Evidence- And consensus-based statements by a panel of Italian experts (Arthritis Res Ther (2019) 21:275 DOI: 10.1186/s13075-019-2021-9) 17
Interleukin-17A (IL-17A): A silent amplifier of COVID-19 17
Mediterranean diet and Psoriatic Arthritis activity: a multicenter cross-sectional study 16
Comparison of effectiveness and safety of infliximab, etanercept, and adalimumab in psoriatic arthritis patients who experienced an inadequate response to previous disease-modifying antirheumatic drugs. 16
Drug retention rates and treatment discontinuation among anti-TNF-α agents in psoriatic arthritis and ankylosing spondylitis in clinical practice 16
Scleromyxedema complicated by dermato-neuro syndrome during pregnancy 16
Psoriatic disease 10 years later 16
Physician's global assessment in psoriatic arthritis: A multicenter GRAPPA study 16
Telerheumatology in COVID-19 era: a study from a psoriatic arthritis cohort 16
Psoriatic disease: Clinical staging 16
Potential Role of Cytochrome c and Tryptase in Psoriasis and Psoriatic Arthritis Pathogenesis: Focus on Resistance to Apoptosis and Oxidative Stress 15
Influenza vaccine with adjuvant on disease activity in psoriatic arthritis patients under anti-TNF-Α therapy 15
PFAPA syndrome and Behçet's disease: a comparison of two medical entities based on the clinical interviews performed by three different specialists 15
Weekly oral alendronate in mevalonate kinase deficiency 15
Totale 2.469
Categoria #
all - tutte 14.158
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.158


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201918 0 0 0 0 0 0 0 0 0 5 1 12
2019/2020369 189 1 4 4 21 13 5 1 7 21 48 55
2020/2021255 50 4 11 10 40 29 10 4 47 13 20 17
2021/2022761 8 6 1 0 2 33 3 34 140 31 125 378
2022/2023805 161 24 25 42 96 76 6 90 103 105 65 12
2023/2024502 32 105 115 47 32 84 19 52 13 3 0 0
Totale 3.113